Larrinaga G - Search Results

1

The role of cancer-associated fibroblasts in renal cell carcinoma. An example of tumor modulation through tumor/non-tumor cell interactions.

Errarte P, Larrinaga G, López JI. Errarte P, et al. Among authors: larrinaga g. J Adv Res. 2019 Sep 17;21:103-108. doi: 10.1016/j.jare.2019.09.004. eCollection 2020 Jan. J Adv Res. 2019. PMID: 32071778 Free PMC article. Review.

2

Altered levels of acid, basic, and neutral peptidase activity and expression in human clear cell renal cell carcinoma.

Varona A, Blanco L, López JI, Gil J, Agirregoitia E, Irazusta J, Larrinaga G. Varona A, et al. Among authors: larrinaga g. Am J Physiol Renal Physiol. 2007 Feb;292(2):F780-8. doi: 10.1152/ajprenal.00148.2006. Epub 2006 Sep 19. Am J Physiol Renal Physiol. 2007. PMID: 16985214 Free article.

3

Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.

Larrinaga G, López JI, Casis L, Blanco L, Gil J, Agirregoitia E, Varona A. Larrinaga G, et al. Regul Pept. 2007 Dec 4;144(1-3):56-61. doi: 10.1016/j.regpep.2007.06.002. Epub 2007 Jun 21. Regul Pept. 2007. PMID: 17692401

4

Acid, basic, and neutral peptidases present different profiles in chromophobe renal cell carcinoma and in oncocytoma.

Blanco L, Larrinaga G, Pérez I, López JI, Gil J, Agirregoitia E, Varona A. Blanco L, et al. Among authors: larrinaga g. Am J Physiol Renal Physiol. 2008 Apr;294(4):F850-8. doi: 10.1152/ajprenal.00469.2007. Epub 2008 Jan 23. Am J Physiol Renal Physiol. 2008. PMID: 18216146 Free article.

5

Increased prolyl endopeptidase activity in human neoplasia.

Larrinaga G, Perez I, Blanco L, López JI, Andrés L, Etxezarraga C, Santaolalla F, Zabala A, Varona A, Irazusta J. Larrinaga G, et al. Regul Pept. 2010 Aug 9;163(1-3):102-6. doi: 10.1016/j.regpep.2010.03.012. Epub 2010 Apr 1. Regul Pept. 2010. PMID: 20362629

6

Expression and activity profiles of DPP IV/CD26 and NEP/CD10 glycoproteins in the human renal cancer are tumor-type dependent.

Varona A, Blanco L, Perez I, Gil J, Irazusta J, López JI, Candenas ML, Pinto FM, Larrinaga G. Varona A, et al. Among authors: larrinaga g. BMC Cancer. 2010 May 11;10:193. doi: 10.1186/1471-2407-10-193. BMC Cancer. 2010. PMID: 20459800 Free PMC article.

7

Changes in cell-surface peptidase activity in papillary renal cell carcinoma.

Blanco L, Perez I, Sanz B, Gil J, López JI, Ugalde A, Varona A, Larrinaga G. Blanco L, et al. Among authors: larrinaga g. Anticancer Res. 2010 Apr;30(4):1137-41. Anticancer Res. 2010. PMID: 20530419

8

Expression of cannabinoid receptors in human kidney.

Larrinaga G, Varona A, Pérez I, Sanz B, Ugalde A, Cándenas ML, Pinto FM, Gil J, López JI. Larrinaga G, et al. Histol Histopathol. 2010 Sep;25(9):1133-8. doi: 10.14670/HH-25.1133. Histol Histopathol. 2010. PMID: 20607655

9

Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors.

Larrinaga G, Pérez I, Sanz B, Blanco L, López JI, Cándenas ML, Pinto FM, Gil J, Irazusta J, Varona A. Larrinaga G, et al. Regul Pept. 2010 Dec 10;165(2-3):218-23. doi: 10.1016/j.regpep.2010.07.170. Epub 2010 Aug 6. Regul Pept. 2010. PMID: 20692300

10

Cannabinoid CB₁ receptor is downregulated in clear cell renal cell carcinoma.

Larrinaga G, Sanz B, Pérez I, Blanco L, Cándenas ML, Pinto FM, Gil J, López JI. Larrinaga G, et al. J Histochem Cytochem. 2010 Dec;58(12):1129-34. doi: 10.1369/jhc.2010.957126. Epub 2010 Sep 17. J Histochem Cytochem. 2010. PMID: 20852034 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters